drugset / Trial / NCT01663935

Vision Response to Dopamine Replacement

NCT01663935

Phase 2 Terminated 20 enrolled University of Wisconsin, Madison
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate and document physiologic and functional changes in visual performance and retinal function of patients diagnosed with albinism (a dopamine deficiency state) following a trial of oral Levodopa/carbidopa treatment.

Timeline

Start
2012-10-17
Primary completion
2018-04-12
Completion
2018-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 4 mg/kg Oral
Subject Levodopa Small molecule 4 mg/kg Oral